151 related articles for article (PubMed ID: 1935801)
1. Cell cycle phase dependence of estrogen and epidermal growth factor (EGF) receptor expression in MCF-7 cells: implications in antiestrogen and EGF cell responsiveness.
Dong XF; Berthois Y; Colomb E; Martin PM
Endocrinology; 1991 Nov; 129(5):2719-28. PubMed ID: 1935801
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogens increase protein tyrosine phosphatase activity in human breast cancer cells.
Freiss G; Vignon F
Mol Endocrinol; 1994 Oct; 8(10):1389-96. PubMed ID: 7854356
[TBL] [Abstract][Full Text] [Related]
3. Mode of EGF action on cell cycle kinetics in human breast cancer cell line MCF-7: some evidence that EGF acts as a "progression factor".
Dong XF; Berthois Y; Dussert C; Isnardon D; Palmari J; Martin PM
Anticancer Res; 1992; 12(6B):2085-92. PubMed ID: 1295452
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
5. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
6. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
7. Laminin inhibits estrogen action in human breast cancer cells.
Woodward TL; Lu H; Haslam SZ
Endocrinology; 2000 Aug; 141(8):2814-21. PubMed ID: 10919267
[TBL] [Abstract][Full Text] [Related]
8. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
9. A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.
Vessières A; Corbet C; Heldt JM; Lories N; Jouy N; Laïos I; Leclercq G; Jaouen G; Toillon RA
J Inorg Biochem; 2010 May; 104(5):503-11. PubMed ID: 20116857
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
Lykkesfeldt AE; Larsen JK; Christensen IJ
Breast Cancer Res Treat; 1986; 7 Suppl():S83-90. PubMed ID: 3742066
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.
Borras M; Jin L; Bouhoute A; Legros N; Leclercq G
Biochem Pharmacol; 1994 Nov; 48(11):2015-24. PubMed ID: 7802690
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286
[TBL] [Abstract][Full Text] [Related]
13. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells.
Jakesz R; Smith CA; Aitken S; Huff K; Schuette W; Shackney S; Lippman M
Cancer Res; 1984 Feb; 44(2):619-25. PubMed ID: 6692367
[TBL] [Abstract][Full Text] [Related]
14. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
[TBL] [Abstract][Full Text] [Related]
15. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
Leung BS; Potter AH
J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells.
van Agthoven T; van Agthoven TL; Portengen H; Foekens JA; Dorssers LC
Cancer Res; 1992 Sep; 52(18):5082-8. PubMed ID: 1516065
[TBL] [Abstract][Full Text] [Related]
17. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
19. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Osborne CK; Boldt DH; Estrada P
Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
[TBL] [Abstract][Full Text] [Related]
20. H-ras dependent estrogenic effects of epidermal growth factor in the estrogen-independent breast cancer cell line MDA-MB-231.
Treeck O; Weber A; Boester M; Porz S; Frey N; Diedrich K; Ortmann O
Breast Cancer Res Treat; 2003 Jul; 80(2):155-62. PubMed ID: 12908818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
